Skip to content

Changes in retinal peripheral refractive status and aberrations before and after Femtosecond Laser-assisted laser in Situ Keratomileusis, Small Incision Lenticule Extraction, and Implantable Collamer Lens Surgery

Changes in retinal peripheral refractive status and aberrations before and after Femtosecond Laser-assisted laser in Situ Keratomileusis, Small Incision Lenticule Extraction, and Implantable Collamer Lens Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108664
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive error

Interventions

Femtosecond laser-assisted in situ keratomileusis group:NA
Small incision lenticule extraction (SMILE) group:NA
Posterior chamber phakic intraocular lens (ICL) group:NA

Sponsors

The Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 50 years, with no restriction on sex. 2. Stable refractive status (annual refractive change less than 0.50 D over the past 2 years). 3. Candidates scheduled for FS-LASIK, SMILE, or ICL surgery, having completed routine preoperative examinations and meeting surgical indications. 4. No significant fundus pathology, with normal ocular structural development. 5. Ability to comply with all preoperative and postoperative examination protocols and willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of, or currently suffering from, any clinically significant diseases of the circulatory, endocrine, neurological, digestive, respiratory, hematological, immunological, psychiatric systems, or metabolic disorders, or any other condition that may interfere with study outcomes. 2. Patients with active ocular infections or undergoing anti-inflammatory treatment. 3. Pregnant or lactating women. 4. Patients with severe psychological or cognitive impairments who are unable to understand the study requirements or provide informed consent. 5. Patients who, for other reasons, are deemed unable to complete the study or are considered unsuitable for inclusion by the investigators.

Design outcomes

Primary

MeasureTime frame
Retinal optical aberrations;Visual Acuity Test;Intraocular Pressure (IOP);Corneal topography;

Countries

China mainland

Contacts

Public ContactHan Wei

The Second Affiliated Hospital, School of Medicine, Zhejiang University

hanweidr@zju.edu.cn+86 137 7745 1901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 20, 2026